Παρακολούθηση
Aidan Hollis
Aidan Hollis
Professor of Economics, University of Calgary
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ucalgary.ca - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals
A Aidara-Kane, FJ Angulo, JM Conly, Y Minato, EK Silbergeld, ...
Antimicrobial Resistance & Infection Control 7, 1-8, 2018
4812018
Microcredit: What can we learn from the past?
A Hollis, A Sweetman
World Development 26 (10), 1875-1891, 1998
3651998
Co-authorship and the output of academic economists
A Hollis
Labour economics 8 (4), 503-530, 2001
2892001
Preserving antibiotics, rationally
A Hollis, Z Ahmed
New England Journal of Medicine 369 (26), 2474-2476, 2013
2572013
The Health Impact Fund: Making New Medicines Accessible for All: a Report of Incentives for Global Health
A Hollis, TWM Pogge, Incentives for Global Health
Incentives for Global Health, 2008
2142008
An economic justification for open access to essential medicine patents in developing countries
S Flynn, A Hollis, M Palmedo
The Journal of Law, Medicine & Ethics 37 (2), 184-208, 2009
1832009
The life-cycle of a microfinance institution: The Irish loan funds
A Hollis, A Sweetman
Journal of Economic Behavior & Organization 46 (3), 291-311, 2001
1322001
The importance of being first: evidence from Canadian generic pharmaceuticals
A Hollis
Health Economics 11 (8), 723-734, 2002
1312002
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
K Jayasundara, A Hollis, M Krahn, M Mamdani, JS Hoch, P Grootendorst
Orphanet journal of rare diseases 14, 1-10, 2019
1282019
Impact of isolation precautions on quality of life: a meta-analysis
A Sharma, DR Pillai, M Lu, C Doolan, J Leal, J Kim, A Hollis
Journal of Hospital Infection 105 (1), 35-42, 2020
1192020
A contractual approach to the gray market
NT Gallini, A Hollis
International Review of Law and Economics 19 (1), 1-21, 1999
1091999
The Health Impact Fund: incentives for improving access to medicines
A Banerjee, A Hollis, T Pogge
Lancet (London, England) 12 (9709), 2010
1072010
Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus
CM Morel, O Lindahl, S Harbarth, MEA de Kraker, S Edwards, A Hollis
The Journal of antibiotics 73 (7), 421-428, 2020
1052020
Microcredit in prefamine Ireland
A Hollis, A Sweetman
Explorations in Economic History 35 (4), 347-380, 1998
1031998
The large-scale integration of wind generation: Impacts on price, reliability and dispatchable conventional suppliers
J MacCormack, A Hollis, H Zareipour, W Rosehart
Energy policy 38 (7), 3837-3846, 2010
1022010
The anti-competitive effects of brand-controlled" pseudo-generics" in the Canadian pharmaceutical market
A Hollis
Canadian Public Policy/Analyse de Politiques, 21-32, 2003
922003
An efficient reward system for pharmaceutical innovation
A Hollis
Retrieved Dec 9, 2004
912004
Attitudes, behaviours and barriers to public health measures for COVID-19: a survey to inform public health messaging
R Lang, JL Benham, O Atabati, A Hollis, T Tombe, B Shaffer, KK Burns, ...
BMC Public Health 21, 1-15, 2021
812021
Antibiotic resistance is a tragedy of the commons that necessitates global cooperation
A Hollis, P Maybarduk
Journal of Law, Medicine & Ethics 43 (S3), 33-37, 2015
752015
Microfinance and famine: the Irish loan funds during the great famine
A Hollis, A Sweetman
World Development 32 (9), 1509-1523, 2004
682004
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20